2022 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦5ȸ µ¿°èÇмú´ëȸ : 2022-01-23±³À°ÀÏÀÚ : 2022-01-23
±³À°Àå¼Ò : ÄÜ·¡µå È£ÅÚ, 5Ãþ ÆÄÅ©º¼·Ò
±³À°ÁÖÁ¦ :
2022 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦5ȸ µ¿°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : Á¤¼Ò¿µ
¿¬¶ôó : 02-512-5915
À̸ÞÀÏ :
office@sgo.or.kr ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í Àü¹®ÀÇ 30,000 Àü°øÀÇ,ÀϹÝÀÇ,¿¬±¸¿ø,°£È£»ç 20,000 ÁÂÀå,¿¬ÀÚ,¸¸65¼¼ÀÌ»ó ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 01-23 ÆÄÅ©º¼·Ò 09:30~09:50 Registration ()
±âŸ 01-23 ÆÄÅ©º¼·Ò 09:50~10:00 Opening Remarks ±è¿µÅÂ(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 10:00~10:20 New recommendations for screening and treatment to prevent cervical cancer (WHO guidelines) À̼ºÁ¾(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 10:20~10:40 Cervical screening: position status of the European Society of Gynecologic Oncology (ESGO) ÁÖ¿õ(ÀÌÈÀÇ´ë)
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 10:40~11:00 Discussion ¹ÚÁ¤¿/Á¤´ëÈÆ/Á¶Çö¿õ(¿ï»êÀÇ´ë/ÀÎÁ¦ÀÇ´ë/°í·ÁÀÇ´ë)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 11:00~11:25 Current Status of Cervical Cancer Screening in Japan Aikou Okamoto(The Jikei University School of Medicine Japan))
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 11:25~11:30 Discussion ½É½ÂÇõ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 11:30~11:55 Newly launched Swedish HPV and screening guidelines Jan Persson(Skane University Sweden)
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 11:55~12:00 Discussion À¯»ó¿µ(¿øÀڷº´¿ø)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 12:00~12:20 Challenges of introducing HPV DNA test into an established opportunistic cervical cancer screening program. The singapore experience Ida Ismail-Pratt(Mount Elizabeth Novena HospitalSingapore)
½Ä»ç 01-23 ÆÄÅ©º¼·Ò 12:20~13:30 Lunch ()
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 13:30~13:55 Role of HPV Test in Cervical Cytology ÀüÀÌ°æ(°í·ÁÀÇ´ë º´¸®ÇÐ)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 13:55~14:20 Currently applicable HPV Tests ¹ÚÀºÇâ(¿¬¼¼ÀÇ´ë º´¸®ÇÐ)
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 14:20~14:35 Discussion ÀÌÁ¤¿ø/À̱ÙÈ£/±è»ó¿î(¼º±Õ°üÀÇ´ë/°¡Å縯ÀÇ´ë/¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 14:35~14:55 National cervical cancer screening program (Korea) ÀÌÀç°ü(°í·ÁÀÇ´ë)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 14:55~15:15 Clinical relevance of the HPV vaccine in women already infected with HPV ½Å¼ÒÁø(°è¸íÀÇ´ë)
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 15:15~15:30 Discussion Á¶ÇѺ°/±è¹Î±Ô/ÀÌ¿ø¹«(¿¬¼¼ÀÇ´ë/¼º±Õ°üÀÇ´ë/ÇѾçÀÇ´ë)
ÈÞ½Ä 01-23 ÆÄÅ©º¼·Ò 15:30~15:50 Coffee Break ()
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 15:50~16:10 Pitfall of imaging studies for FIGO staging by PET ÀüÅÂÁÖ(¿¬¼¼ÀÇ´ë ÇÙÀÇÇаú)
±³À°½Ã°£ 01-23 ÆÄÅ©º¼·Ò 16:10~16:30 Current HPV status around the world ÀÓ°¡¿ø(µ¿±¹ÀÇ´ë)
Åä·Ð 01-23 ÆÄÅ©º¼·Ò 16:30~16:45 Discussion ÀÓ¸íö/°øÅ¿í/¼Ò°æ¾Æ(±¹¸³¾Ï¼¾ÅÍ/¾ÆÁÖÀÇ´ë/°Ç±¹ÀÇ´ë)
±âŸ 01-23 ÆÄÅ©º¼·Ò 16:45~16:50 Closing Remarks ()